Max Healthcare Institute logo

Max Healthcare Institute financials: balance sheet, profit and loss, cash flow

NSE: MAXHEALTHBSE: 543220Healthcare ServicesMid Cap

Max Healthcare Institute Limited · Face value ₹10 · Listed Aug 2020
Last close ₹860.00up ₹8.85 (1.04%)BSE ₹860.00

Share price at the NSE close on 30 Oct 2026. Previous close ₹851.15.

30 Oct: open ₹851.00, high ₹882.95, low ₹849.40

52-week range of traded prices to 30 Oct 2026
₹797.00Low, 22 Oct 2026₹1,189.00High, 30 Oct 2025
Market cap
₹83,705 Cr111th largest listed
P/E
60.61
P/B
7.39
Dividend yield
0.23%
ROE
12.9%
ROCE
12.7%
Debt to equity
0.33
Volume, NSE
68,79,39761.2% delivered

Max Healthcare Institute's financial statements for the 6 years to Mar 2026, consolidated: the company and its subsidiaries together, with the half year to Sep 2026 after them.

6 years at a glance

₹ crore, years to March.Max Healthcare Institute annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
2,505−138897Mar 213,931605727Mar 224,5631,104689Mar 235,4061,0581,299Mar 247,0281,0763,010Mar 258,3731,4423,478Mar 26
Peak revenue ₹8,373 Cr, year to Mar 2026; lowest ₹2,505 Cr, year to Mar 2021A loss in 1 of the 6 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
27.6%−5.5%16.1%24.0%27.2%27.6%26.3%26.8%−5.5%15.4%24.2%19.6%15.3%17.2%Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue8,373
  2. Materials and goods−1,790
  3. Employee costs−1,357
  4. Other expenses−2,983
  5. Operating profit2,243
  6. Depreciation−447
  7. Other income+163
  8. One-off items−48
  9. Finance costs−235
  10. Profit before tax1,676
  11. Tax−233
  12. Net profit1,442

What the company owns

  • Plant, investments and other assets₹15,446 Cr
  • Receivables₹970 Cr
  • Cash and bank₹701 Cr
  • Inventory₹114 Cr

What pays for it: net worth and liabilities

  • Net worth₹10,747 Cr
  • Borrowings₹3,478 Cr
  • Other liabilities₹2,147 Cr
  • Owed to suppliers₹859 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Sep 2026, the latest four quarters added.Max Healthcare Institute quarterly results

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 21 MaySep 2026Twelve monthsFiled 30 Oct
Revenue from operations2,5053,9314,5635,4067,0288,3739,146
2,1012,9893,3223,9145,1806,1316,691
Materials and goods bought5949239221,1191,4771,7901,909
Employee costs5897608099341,1741,3571,468
Other expenses9181,3061,5911,8612,5292,9833,314
Operating profit before depreciation4049431,2411,4921,8492,2432,455
Operating margin16.1%24.0%27.2%27.6%26.3%26.8%26.8%
Materials, % of revenue23.7%23.5%20.2%20.7%21.0%21.4%20.9%
Employee costs, % of revenue23.5%19.3%17.7%17.3%16.7%16.2%16.1%
Other expenses, % of revenue36.6%33.2%34.9%34.4%36.0%35.6%36.2%
Depreciation and amortisation174221232245359447504
Operating profit after depreciation2307211,0081,2471,4891,7961,951
Other income115127139178156163175
Finance costs1791018460165235271
Profit before one-off items and tax1657481,0641,3651,4801,7241,855
One-off items−234−900−74−48−48
Profit before tax−697391,0641,3651,4061,6761,806
46134−40308330233426
Share of profit of joint ventures and associates−23––––––
−1386051,1041,0581,0761,4421,381
Other comprehensive income130−6−5−24
Total comprehensive income−1376081,1031,0511,0711,4411,385
Net margin−5.5%15.4%24.2%19.6%15.3%17.2%15.1%
Net margin without joint ventures and associates−4.6%––––––

Balance sheet

Consolidated, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 21 MaySep 2026Half yearFiled 30 Oct
5,6396,2827,4108,4089,38110,74711,533
5,6396,2827,4108,4089,38110,74711,332
Share capital966970971972972973973
Reserves4,6735,3136,4397,4368,4099,77410,359
Belonging to outside owners of subsidiaries000000201
8977276891,2993,0103,4783,795
7777571,0461,2491,8142,1872,493
2,1292,1491,6472,3434,0204,2974,696
Total assets8,5449,18910,10212,00015,21417,23118,722
7,4208,1898,15910,29413,62215,28616,626
1,1241,0001,9431,7061,5931,9452,096
Net debt244227−7792002,3282,7783,224
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only.

Cash flow

Consolidated, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 21 MaySep 2026Half year
1187481,2091,1221,4601,633995
608401,3701,3911,7812,0051,158
−376−13281−159−124−263−233
Receivables56365−109−209−323−303
Inventories17−8−156−19−9−14
Payables3−469978817394
Other working capital−452−81−68−13523−4−10
Tax paid58−109−161−269−321−372−163
Interest paid09000000
Capital spending1185613367799661,485589
Free cash flow−1187874343494149406
−73−772−1,187−1,285−1,632−1,689−988
191−294−289−264−16459−117
Dividends paid00097146146194
Shares bought back0000000
Shares issued1,179411000
Net change in cash236−317−266−427−3364−109
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.Max Healthcare Institute dividend history

₹ per shareMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 21 May
Earnings per share−₹1.59₹6.25₹11.38₹10.89₹11.07₹14.83
Diluted earnings per share−₹1.59₹6.24₹11.36₹10.84₹11.01₹14.76
Dividend per share––₹1.00₹1.50₹1.50₹2.00
Book value per share₹58.37₹64.79₹76.32₹86.51₹96.50₹110.43
Dividend payout––8.8%13.9%13.6%13.5%
Shareholder yield−6.3%0.0%0.0%0.1%0.1%0.2%
Market cap at the year end (₹ crore)18,61133,70842,81979,6801,06,63893,610

Ratios

Consolidated, years to March.Max Healthcare Institute PE ratio and valuation

RatioMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 21 May
Revenue growth–57.0%16.1%18.5%30.0%19.1%
Operating profit growth–133.4%31.6%20.3%23.9%21.3%
Net profit growth––82.4%−4.2%1.7%34.1%
Earnings per share growth––82.0%−4.3%1.7%34.0%
−2.4%10.2%16.1%13.3%12.1%14.3%
–12.6 pts6.0 pts−2.8 pts−1.2 pts2.2 pts
From the net margin–9.3 pts5.8 pts−3.2 pts−2.8 pts1.5 pts
From asset turnover–3.5 pts1.1 pts0.4 pts0.6 pts0.0 pts
From borrowing–−0.2 pts−0.9 pts−0.1 pts1.0 pts0.7 pts
Return on capital employed3.5%10.3%12.5%12.8%12.0%12.6%
Cash conversion–123.7%109.6%106.1%135.7%113.2%
Interest cover1.37.212.020.89.07.6
Debt to equity0.160.120.090.150.320.32
Receivable days533627313642
Inventory days332430262623
Payable days268179215221200175
Cash conversion cycle, days−181−119−158−164−138−110
Working capital days−37−15−39−36−34−19
Asset turnover0.290.440.470.490.520.52
Assets per rupee of net worth1.521.491.411.401.531.61
Sales per rupee of plant1.432.012.261.671.291.20
Capital spending to depreciation0.682.541.453.182.693.32
Plant being built, % of plant in use1.5%5.4%10.2%13.7%16.5%8.5%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
8.9%
Cash from operations against operating profit
72.8%
Measure5 years3 years
Revenue growth, yearly rate27.3%22.4%
Profit growth, yearly rate–9.3%
Return on equity, average13.2%13.2%
Return on capital employed, average12.0%12.5%
Operating margin, average26.4%26.9%
Net margin, average18.3%17.4%
Asset turnover, average0.490.51
Cash conversion cycle, days, average−138−137
Interest cover, average11.312.5
Debt to equity, average0.200.27

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations6,1724,2151,633
Cash from investing−6,565−4,606−1,689
Cash from financing−951−36859
Capital spending4,1263,2291,485
Dividends paid388388146
Shares bought back000
Shares issued for cash610
Borrowings raised2,6232,559568
Borrowings repaid2,1801,761144

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––8446
Altman Z-scorePublished threshold 1.815.258.5311.3715.0712.5310.29
Beneish M-scorePublished threshold −1.78–−2.27−2.70−2.22−2.38−2.24
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–7.0911.2111.059.179.23
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––1.321.111.171.18
Receivables growth less revenue growthOur threshold 0 percentage points–−51.64−28.8319.1718.5321.96
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−41.2124.33−16.580.97−13.59
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–0.130.240.030.600.64
Assets under construction, years of additionsOur threshold 2 years of additions–0.250.690.300.350.30
Effective tax ratePublished threshold 17.16 per cent–18.11−3.7422.5423.5013.92
Tax charged less tax paid, % of profitOur threshold 10 percentage points–3.35−18.892.810.68−8.28
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
12 Oct 2026CARE Ratings LimitedFund-based - LT-Term LoanLong-term scaleCARE AA+Review, Re-affirmStable1,688.88
12 Oct 2026CARE Ratings LimitedFund-based - LT-Working Capital LimitsLong-term scaleCARE AA+Review, Re-affirmStable130
12 Oct 2026CARE Ratings LimitedNon-fund-based - ST-BG/LCShort-term scaleCARE A1+Review, Re-affirm80
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.